Latitude and psoriasis prevalence.
Jacobson, Christine C, Sandeep Kumar, and Alexa B Kimball. 2011. “Latitude and Psoriasis Prevalence.”. Journal of the American Academy of Dermatology 65 (4): 870-73.
Search
Search results
375 results found
Efficacy and safety of ABT-874, a monoclonal anti-interleukin 12/23 antibody, for the treatment of chronic plaque psoriasis: 36-week observation/retreatment and 60-week open-label extension phases of a randomized phase II trial.
Kimball, Alexa B, Kenneth B Gordon, Richard G Langley, Alan Menter, Renee J Perdok, Joaquin Valdes, and ABT-874 Study Investigators. 2011. “Efficacy and Safety of ABT-874, a Monoclonal Anti-Interleukin 12/23 Antibody, for the Treatment of Chronic Plaque Psoriasis: 36-Week Observation/Retreatment and 60-Week Open-Label Extension Phases of a Randomized Phase II Trial.”. Journal of the American Academy of Dermatology 64 (2): 263-74.
Psoriasis: is the impairment to a patient's life cumulative?
Kimball, A B, U Gieler, D Linder, F Sampogna, R B Warren, and M Augustin. 2010. “Psoriasis: Is the Impairment to a Patient’s Life Cumulative?”. Journal of the European Academy of Dermatology and Venereology : JEADV 24 (9): 989-1004.
Coronary heart disease and stroke risk in patients with psoriasis: retrospective analysis.
Kimball, Alexa Boer, Annie Guérin, Dominick Latremouille-Viau, Andrew P Yu, Shiraz Gupta, Yanjun Bao, and Parvez Mulani. 2010. “Coronary Heart Disease and Stroke Risk in Patients With Psoriasis: Retrospective Analysis.”. The American Journal of Medicine 123 (4): 350-7.
Seasonal variation of acne and psoriasis: A 3-year study using the Physician Global Assessment severity scale.
Pascoe, Vanessa Lindsay, and Alexandra Boer Kimball. 2015. “Seasonal Variation of Acne and Psoriasis: A 3-Year Study Using the Physician Global Assessment Severity Scale.”. Journal of the American Academy of Dermatology 73 (3): 523-5.
Remission of psoriasis 13 years after autologous stem cell transplant.
Sung, Sarah M, and Alexa B Kimball. 2015. “Remission of Psoriasis 13 Years After Autologous Stem Cell Transplant.”. Cutis 95 (6): E7-8.
A measure of chronic quality of life predicts socioeconomic and medical outcomes in psoriasis patients.
Kim, G E, E Seidler, and A B Kimball. 2015. “A Measure of Chronic Quality of Life Predicts Socioeconomic and Medical Outcomes in Psoriasis Patients.”. Journal of the European Academy of Dermatology and Venereology : JEADV 29 (2): 249-54.
OBSERVE-5: observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results.
Kimball, Alexa B, Kenneth J Rothman, Gregory Kricorian, David Pariser, Paul S Yamauchi, Alan Menter, Craig F Teller, et al. 2015. “OBSERVE-5: Observational Postmarketing Safety Surveillance Registry of Etanercept for the Treatment of Psoriasis Final 5-Year Results.”. Journal of the American Academy of Dermatology 72 (1): 115-22.
Psoriasis epidemiology: the interplay of genes and the environment.
Enamandram, Monica, and Alexa B Kimball. 2013. “Psoriasis Epidemiology: The Interplay of Genes and the Environment.”. The Journal of Investigative Dermatology 133 (2): 287-9.
Adverse Reactions to Biologics in Psoriasis.
Lockwood, Stephen J, Lisette M Prens, and Alexa B Kimball. 2018. “Adverse Reactions to Biologics in Psoriasis.”. Current Problems in Dermatology 53: 1-14.